2018
Higher spermidine intake is linked to lower mortality: a prospective population-based study
KIECHL, Stefan, Raimund PECHLANER, Peter WILLEIT, Marlene NOTDURFTER, Bernhard PAULWEBER et. al.Základní údaje
Originální název
Higher spermidine intake is linked to lower mortality: a prospective population-based study
Autoři
KIECHL, Stefan (40 Rakousko, garant), Raimund PECHLANER (40 Rakousko), Peter WILLEIT (40 Rakousko), Marlene NOTDURFTER (826 Velká Británie a Severní Irsko), Bernhard PAULWEBER (40 Rakousko), Karin WILLEIT (40 Rakousko), Philipp WERNER (40 Rakousko), Christoph RUCKENSTUHL (40 Rakousko), Bernhard IGLSEDER (40 Rakousko), Siegfried WEGER (380 Itálie), Barbara MAIRHOFER (380 Itálie), Markus GARTNER (380 Itálie), Ludmilla KEDENKO (40 Rakousko), Monika CHMELÍKOVÁ (203 Česká republika, domácí), Slaven STEKOVIC (40 Rakousko), Hermann STUPPNER (40 Rakousko), Friedrich OBERHOLLENZER (380 Itálie), Guido KROEMER (250 Francie), Manuel MAYR (826 Velká Británie a Severní Irsko), Tobias EISENBERG (40 Rakousko), Herbert TILG (40 Rakousko), Frank MADEO (40 Rakousko) a Johann WILLEIT (40 Rakousko)
Vydání
American Journal of Clinical Nutrition, Bethesda, American Society for Nutrition, 2018, 0002-9165
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30308 Nutrition, Dietetics
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 6.568
Kód RIV
RIV/00216224:14110/18:00104191
Organizační jednotka
Lékařská fakulta
UT WoS
000444407100017
Klíčová slova anglicky
polyamines; spermidine; life span; cancer; vascular disease
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 13:30, Soňa Böhmová
Anotace
V originále
Background: Spermidine administration is linked to increased survival in several animal models. Objective: The aim of this study was to test the potential association between spermidine content in diet and mortality in humans. Design: This prospective community-based cohort study included 829 participants aged 45-84 y, 49.9% of whom were male. Diet was assessed by repeated dietitian-administered validated food-frequency questionnaires (2540 assessments) in 1995, 2000, 2005, and 2010. During follow-up between 1995 and 2015, 341 deaths occurred. Results: All-cause mortality (deaths per 1000 person-years) decreased across thirds of increasing spermidine intake from 40.5 (95% CI: 36.1, 44.7) to 23.7 (95% CI: 20.0, 27.0) and 15.1 (95% CI: 12.6, 17.8), corresponding to an age-, sex-and caloric intake-adjusted 20-y cumulative mortality incidence of 0.48 (95% CI: 0.45, 0.51), 0.41 (95% CI: 0.38, 0.45), and 0.38 (95% CI: 0.34, 0.41), respectively. The age-, sex-and caloric ratio-adjusted HR for all-cause death per 1-SD higher spermidine intake was 0.74 (95% CI: 0.66, 0.83; P < 0.001). Further adjustment for lifestyle factors, established predictors of mortality, and other dietary features yielded an HR of 0.76 (95% CI: 0.67, 0.86; P < 0.001). The association was consistent in subgroups, robust against unmeasured confounding, and independently validated in the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR) Study (age-, sex-, and caloric ratioadjusted HR per 1-SD higher spermidine intake: 0.71; 95% CI: 0.53, 0.95; P = 0.019). The difference in mortality risk between the top and bottom third of spermidine intakes was similar to that associated with a 5.7-y (95% CI: 3.6, 8.1 y) younger age. Conclusion: Our findings lend epidemiologic support to the concept that nutrition rich in spermidine is linked to increased survival in humans.